ARCHIVES

ODAC Rejects Amsacrine NDA, Renews Idarubicin

This article is from The Cancer Letter archive.

Vol. 16 No. 35 | September 14, 1990

Download PDF Visit The Full Archive

Related Articles

Komen Officials Say Charity is Stabilizing Despite 22 Percent Drop in Contributions

January 24, 2014

Medicare’s 21% Pay Cut In Effect Today; Congress Unlikely To Abandon SGR

June 18, 2010

Clinical Trials Approved By NCI

September 26, 2003

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002

Alternating Mammography, MRI Tested For High-Risk Women

January 30, 2009

Rauscher Summarizes Criticism of Cooperative Groups; Changes To Await May 22024 Conference

May 9, 1975